Risk-Adapted Donor Selection in Patients with Acute Myeloid Leukemia.
BACKGROUND The optimal donor for adults with acute myeloid leukemia (AML) who lack a matched sibling donor (MSD) remains uncertain in Asian practice, where antithymocyte globulin (ATG)-based graft-versus-host disease (GvHD) prophylaxis is common. OBJECTIVES To compare outcomes after MSD, matched unrelated donor (MUD)...